IT8147792A0 - Carbotioati androstanici procedimento per prepararli e composizioni farmaceutiche che li contengono - Google Patents
Carbotioati androstanici procedimento per prepararli e composizioni farmaceutiche che li contengonoInfo
- Publication number
- IT8147792A0 IT8147792A0 IT8147792A IT4779281A IT8147792A0 IT 8147792 A0 IT8147792 A0 IT 8147792A0 IT 8147792 A IT8147792 A IT 8147792A IT 4779281 A IT4779281 A IT 4779281A IT 8147792 A0 IT8147792 A0 IT 8147792A0
- Authority
- IT
- Italy
- Prior art keywords
- carbotioates
- androstan
- preparing
- procedure
- contain
- Prior art date
Links
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8005174 | 1980-02-15 | ||
| GB8013339 | 1980-04-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8147792A0 true IT8147792A0 (it) | 1981-02-13 |
| IT1170717B IT1170717B (it) | 1987-06-03 |
Family
ID=26274505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT47792/81A IT1170717B (it) | 1980-02-15 | 1981-02-13 | Carbotioati androstanici procedimento per prepararli e composizioni farmaceutiche che li contengono |
Country Status (23)
| Country | Link |
|---|---|
| KR (1) | KR850000969B1 (it) |
| AT (1) | AT395427B (it) |
| AU (1) | AU544517B2 (it) |
| BG (1) | BG60700B2 (it) |
| CH (2) | CH644615A5 (it) |
| CZ (1) | CZ281275B6 (it) |
| DE (2) | DE3105307A1 (it) |
| DK (1) | DK147022C (it) |
| ES (5) | ES499394A0 (it) |
| FI (1) | FI70904C (it) |
| FR (2) | FR2477156A1 (it) |
| HK (1) | HK58385A (it) |
| IE (1) | IE51394B1 (it) |
| IT (1) | IT1170717B (it) |
| KE (1) | KE3526A (it) |
| MX (1) | MX9202717A (it) |
| MY (1) | MY8500757A (it) |
| NL (2) | NL191792C (it) |
| NZ (1) | NZ196260A (it) |
| PT (1) | PT72502B (it) |
| SE (1) | SE452468B (it) |
| SG (1) | SG36885G (it) |
| SK (1) | SK403491A3 (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA817929B (en) * | 1980-12-22 | 1982-10-27 | Upjohn Co | 5alpha-and 5beta-androstane-17beta-carboxylates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1436549A (en) * | 1972-06-15 | 1976-05-19 | Glaxo Lab Ltd | 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters |
| GB1438940A (en) * | 1972-07-19 | 1976-06-09 | Glaxo Lab Ltd | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids |
| GB1514476A (en) * | 1974-08-30 | 1978-06-14 | Glaxo Lab Ltd | Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates |
| US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| GB1580517A (en) * | 1978-04-06 | 1980-12-03 | Fowler I | Crutches |
-
1981
- 1981-02-13 SE SE8101010A patent/SE452468B/sv not_active IP Right Cessation
- 1981-02-13 ES ES499394A patent/ES499394A0/es active Granted
- 1981-02-13 FR FR8102818A patent/FR2477156A1/fr active Granted
- 1981-02-13 CH CH98281A patent/CH644615A5/de not_active IP Right Cessation
- 1981-02-13 AU AU67298/81A patent/AU544517B2/en not_active Expired
- 1981-02-13 IE IE282/81A patent/IE51394B1/en active Protection Beyond IP Right Term
- 1981-02-13 PT PT72502A patent/PT72502B/pt unknown
- 1981-02-13 FI FI810444A patent/FI70904C/fi not_active IP Right Cessation
- 1981-02-13 AT AT0067481A patent/AT395427B/de not_active IP Right Cessation
- 1981-02-13 IT IT47792/81A patent/IT1170717B/it active Protection Beyond IP Right Term
- 1981-02-13 DE DE19813105307 patent/DE3105307A1/de active Granted
- 1981-02-13 CH CH3890/84A patent/CH651307A5/de not_active IP Right Cessation
- 1981-02-13 DK DK62381A patent/DK147022C/da not_active IP Right Cessation
- 1981-02-13 NZ NZ196260A patent/NZ196260A/xx unknown
- 1981-02-13 KR KR1019810000442A patent/KR850000969B1/ko active
- 1981-02-13 NL NL8100707A patent/NL191792C/xx not_active IP Right Cessation
- 1981-02-13 DE DE3153379A patent/DE3153379C2/de not_active Expired - Lifetime
- 1981-08-17 FR FR8115812A patent/FR2485542A1/fr active Granted
-
1982
- 1982-02-12 ES ES509539A patent/ES509539A0/es active Granted
- 1982-12-14 ES ES518161A patent/ES518161A0/es active Granted
-
1983
- 1983-08-16 ES ES524985A patent/ES524985A0/es active Granted
-
1984
- 1984-04-30 ES ES532055A patent/ES8600936A1/es not_active Expired
-
1985
- 1985-05-13 KE KE3526A patent/KE3526A/xx unknown
- 1985-05-16 SG SG368/85A patent/SG36885G/en unknown
- 1985-08-08 HK HK583/85A patent/HK58385A/xx not_active IP Right Cessation
- 1985-12-30 MY MY757/85A patent/MY8500757A/xx unknown
-
1991
- 1991-12-23 SK SK4034-91A patent/SK403491A3/sk unknown
- 1991-12-23 CZ CS914034A patent/CZ281275B6/cs unknown
-
1992
- 1992-06-05 MX MX9202717A patent/MX9202717A/es unknown
-
1993
- 1993-08-20 BG BG98060A patent/BG60700B2/bg unknown
-
1996
- 1996-10-29 NL NL960029C patent/NL960029I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8348422A0 (it) | Composti eterociclici, procedimento per prpararli e composizioni farmaceutiche che li contengono | |
| IT8149407A0 (it) | Derivato di amminoalchilfurano procedimento per produrlo e composizione farmaceutica che lo contiene | |
| BR1100036A (pt) | Composto e composição farmacêutica | |
| IT1123536B (it) | Derivati di spiro-ossazolidindioni e composizioni farmaceutiche che li contengono | |
| NZ188721A (en) | Imidazolidines and pharmaceutical compositions | |
| IT8149680A0 (it) | Composti carbostirilici composizioni che li contengono e procedimenti per prepararli | |
| IT8048262A0 (it) | Composti chinolonici composizioni terapeutiche che li contengono eprocedimento per prepararli | |
| IT1162879B (it) | Composizioni farmaceutiche | |
| IT8348155A0 (it) | Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono | |
| IT8548093A1 (it) | Eteri amminociclopentilici procedimento per prepararli e composizione farmaceutica che li comprende | |
| IT7848941A0 (it) | Composti di cefalospirina composizioni antibiotiche che li contengono e procedimento per prepararli | |
| IT8147537A0 (it) | Composizione farmaceutica a cessione prolungata e procedimento per prepararla | |
| IT7850095A0 (it) | Peptidi e composizioni farmaceutiche che li contengono | |
| IT7851815A0 (it) | Derivati di naftotriazoli composizioni farmaceutiche che li contengono e procedimento per prepararli | |
| GB1544191A (en) | Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them | |
| IT8049163A0 (it) | Fenossiammine eterocicliche sostituite procedimento per prepararle e composizioni farmaceutiche che le contengono | |
| IT1141137B (it) | Peptidi e composizioni farmaceutiche che li contengono | |
| IT7950714A0 (it) | Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono | |
| IT7851494A0 (it) | N-benzil-antracicline procedimento per prepararle e composizioni farmaceutiche che le contengono | |
| IT8048308A0 (it) | Derivati benzotiazolici procedimento per prepararli e composizioni farmaceutiche che li contengono | |
| IT8148901A0 (it) | Composti amminosteroidi composizioni farmaceutiche che li contengono e procedimento per prepararli | |
| IT8147792A0 (it) | Carbotioati androstanici procedimento per prepararli e composizioni farmaceutiche che li contengono | |
| IT7852414A0 (it) | Composizione farmaceutica antidiarroica e procedimento per prepararla | |
| IT7949403A0 (it) | Imminotiazolil ureido cefalosporine composizioni farmaceutiche che le contengono e procedimento per la loro preparazione | |
| IT8448800A1 (it) | Amminociclopentani composizioni farmaceutiche che li contengono e procedimento per la loro preparazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ITCP | Complementary protection certificate |
Free format text: CCP 473 |
|
| MEDD | Supplementary protection certificate for pharmaceutical products: granted |
Free format text: CCP 473, 19930730; GLAXO GROUP LIMITED |
|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970225 |